You are about to go to a non-NYULMC website.
Biosketch / Results /
Kepal N. Patel, M.D.
Assistant Professor;Departments of Surgery (Endocrine Division), Biochemistry and Molecular Pharmacology and Otolaryngology (Otolaryngology)
NYU Endocrine Surgery Associates
Clinical Addresses
530 FIRST AVENUE, SUITE 6HNEW YORK, NY 10016
Hours: Mon. 9 - 5; Tue. 9 - 5; Wed. 9 - 5; Thu. 9 - 5; Fri. 9 - 5
Handicap Access: yes
Phone: 212-263-7710
Fax: 212-263-2828
Medical Specialties
Cancer, General SurgeryMedical Expertise
Head & Neck Surgery, Endocrine Surgery, Thyroid Surgery, Head & Neck Cancer, Parathyroid SurgeryClinical Responsibilities
I am a surgeon who has particular expertise in the multidisciplinary treatment of Thyroid and Parathyroid tumors. My expertise extends to all head and neck tumors including cancers of the mouth, throat, voice box, parotid and other salivary glands, skin, melanoma, soft tissue, nerves and blood vessels of the neck.Languages
SpanishInsurance
AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO, AMERICAN IMAGING NETWORK, Beech St PPO, Cigna HMO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, GHI CBP, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MAGNACARE PPO, MULTIPLAN/PHCS PPO, Medicare, NY MEDICAID, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare, UHC COMMUNITY & STATE PLAN, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS, UHC PPO, UHC TOP TIERInsurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.
Board Certification
2003 — Ab Surgery - SurgeryEducation
1996 — Robert Wood Johnson Medical School, Medical Education1996-2002 — Robert Wood Johnson Univ. Hosp. (Surgery (General)), Residency Training
2002-2004 — Memorial Sloan-Kettering Cancer Center (Head & Neck), Clinical Fellowships
Research Summary
The optimal management of thyroid cancer is dependent on the assessment of the malignant potential of the individual tumor at presentation. Understanding the genetic mechanisms controlling thyroid tumor progression can provide valuable prognostic markers and potential therapeutic targets. Our research focuses on the changes in intracellular molecular pathways that lead to the progression of thyroid cancer. When these pathways are understood, specific drugs can be developed to block these changes. By comparing genomic differences between different thyroid cancers, our laboratory has identified genes that may play a role in determining their behavior. Furthermore, we have identified molecular factors that potentially promote thyroid cancer metastases. We are developing new strategies to target the genes associated with aggressive thyroid cancer behavior. By understanding the biology of individual tumors, we will be able to create personalized cancer treatment plans for our patients. I have joint appointments in Surgery and Biochemistry, and have been recruited to lead the endocrine surgery research program.Research Interests
Our laboratory has been interested in studying the molecular pathogenesis of thyroid carcinoma, specifically trying to identify molecular factors which can help predict thyroid tumor progression and potentially serve as therapeutic targets.All data from NYU Health Sciences Library Faculty Bibliography — -
Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities
Gupta, Sachin; Ajise, Oluyomi; Dultz, Linda; Wang, Beverly; Nonaka, Daisuke; Ogilvie, Jennifer; Heller, Keith S; Patel, Kepal N
2012 Mar;138(3):227-233, Archives of otolaryngology, head & neck surgery
—
id: 160751,
year: 2012,
vol: 138,
page: 227,
stat: Journal Article,
Late Solitary Metastasis of Renal Cell Carcinoma to the Submandibular Gland
Serouya, SM; Dultz, LA; Concors, SJ; Wang, B; Patel, KN
2012 Jan;:2356-2359, Journal of oral & maxillofacial surgery
—
id: 159139,
year: 2012,
vol: ,
page: 2356,
stat: Journal Article,
Impact of the 2009 American Thyroid Association guidelines on the choice of operation for well-differentiated thyroid microcarcinomas
Ogilvie, Jennifer B; Patel, Kepal N; Heller, Keith S
2010 Dec;148(6):1222-6; discussion 1226, Surgery
—
id: 115280,
year: 2010,
vol: 148,
page: 1222,
stat: Journal Article,
Spry2 expression correlates with BRAF mutation in thyroid cancer
Xu, Lizhong; Zhou, Jun Liang; Cohen, Michael; Bar-Sagi, Dafna; Patel, Kepal N
2010 Dec;148(6):1282-7; discussion 1287, Surgery
—
id: 115281,
year: 2010,
vol: 148,
page: 1282,
stat: Journal Article,
Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications
Ghossein, Ronald A; Leboeuf, Rebecca; Patel, Kepal N; Rivera, Michael; Katabi, Nora; Carlson, Diane L; Tallini, Giovanni; Shaha, Ashok; Singh, Buvanesh; Tuttle, R Michael
2007 Jul;17(7):655-661, Thyroid
—
id: 74369,
year: 2007,
vol: 17,
page: 655,
stat: Journal Article,
Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes
Andruchow, Jennifer L; Veness, Michael J; Morgan, Gary J; Gao, Kan; Clifford, Anthony; Shannon, Kerwin F; Poulsen, Michael; Kenny, Lizbeth; Palme, Carsten E; Gullane, Patrick; Morris, Christopher; Mendenhall, William M; Patel, Kepal N; Shah, Jatin P; O'Brien, Christopher J
2006 Mar 1;106(5):1078-1083, Cancer
—
id: 74364,
year: 2006,
vol: 106,
page: 1078,
stat: Journal Article,
Poorly differentiated and anaplastic thyroid cancer
Patel, Kepal N; Shaha, Ashok R
2006 Apr;13(2):119-128, Cancer control
—
id: 74366,
year: 2006,
vol: 13,
page: 119,
stat: Journal Article,
Genetic considerations in thyroid cancer
Patel, Kepal N; Singh, Bhuvanesh
2006 Apr;13(2):111-118, Cancer control
—
id: 74365,
year: 2006,
vol: 13,
page: 111,
stat: Journal Article,
Staphylococcal liver abscess and acute cholecystitis in a patient with Crohn's disease receiving infliximab
Patel, Tushar R; Patel, Kepal N; Boyarsky, Andrew H
2006 Jan;10(1):105-110, Journal of gastrointestinal surgery
—
id: 74363,
year: 2006,
vol: 10,
page: 105,
stat: Journal Article,
Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas
Sarkaria, Inderpal; O-charoenrat, Pornchai; Talbot, S

